Supreme Hires Chief Information Officer

MARCH 08, 2018

TORONTO March 8, 2018 /CNW/ – The Supreme Cannabis Company, Inc. (“Supreme” or the “Company”) (TSXV:FIRE), is pleased to announce the hiring of Mr. Chander Batra as the Company’s Chief Information Officer. Mr. Batra will guide the Company’s information efforts and streamline systems among its subsidiaries as Supreme expands and executes its global development initiatives.

Mr. Batra comes to Supreme with more than twenty-seven years of experience in IT transformation, governance and strategy, having held numerous senior leadership positions at industry leaders in the banking, food manufacturing, logistics and supply chain, and pharmaceuticals industries.

Prior to joining Supreme, Mr. Batra was the Global Head of Information Services at Apotex Pharmachem Inc. the fully integrated API division of Apotex, the largest generic pharmaceutical company in Canada . At Apotex Pharmachem, Mr. Batra was responsible for the strategic alignment of business and IT, IS and IT transformation, technology strategy and planning, and global program management for delivering ERP and other enterprise applications. Prior to Apotex, Mr. Batra worked with McCain Foods Ltd. leading their global IT systems development, providing solutions for eCommerce, supply chain optimization, ERP revitalization and business intelligence. Throughout his career, he has worked with various ERPs, security systems, manufacturing and execution systems. He is also well versed with regulatory compliance requirements, having attended many Health Canada, FDA, MHRA and TGA audits.

“Supreme is pleased to announce Mr. Chander Batra as the Company’s Chief Information Officer. Over the course of his career, Mr. Batra has been a leader in IT governance and strategy, and his leadership will be indispensable as we aggressively rollout our domestic and international development strategies,” said John Fowler, CEO of Supreme. “Our Company’s dedication to quality includes the quality of our senior leadership team, and I look forward to working with Mr. Batra as we continue to grow Supreme into a leading cultivator of premium cannabis.”

Mr. Batra holds an Executive MBA from the University of Toronto (Rotman), MSc in Operational Research and BSc in Computer Systems from Delhi University, India .

The Company granted 200,000 stock options (each an “Option”) to Mr. Batra pursuant to the Company’s Amended and Restated Incentive Stock Option Plan (the “Plan”). Each Option has an exercise price of $2.05 and is exercisable into one common share, subject to certain vesting conditions and the terms and conditions of the Plan, and expire on March 5, 2023.

About Supreme

Supreme is a Canadian publicly traded company committed to becoming a leading cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of medical cannabis pursuant to the ACMPR operating inside a 342,000 sq. ft. hybrid greenhouse facility. The hybrid greenhouse combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint. Please visit and for more information.

Forward-Looking Information

Certain statements made in this press release may constitute forward-looking information under applicable securities laws. These statements may relate to anticipated events or results and  include, but are not limited to, expectations regarding our regulatory environment and potential changes in law, expectations regarding the rollout our domestic and international development strategies, our ability to streamline systems among its subsidiaries, technology and operations and other statements that are not historical facts. Particularly, information regarding our expectations of future results, targets, performance achievements, prospects or opportunities is forward-looking information. Often, but not always, forward-looking statements can be identified by the use of forward-looking terminology such as “may” “will”, “expect”, “believe”, “estimate”, “plan”, “could”, “should”, “would”, “outlook”, “forecast”, “anticipate”, “foresee”, “continue” or the negative of these terms or variations of them or similar terminology. Forward-looking statements are current as of the date they are made and are based on applicable estimates and assumptions made by us at the relevant time in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we believe are appropriate and reasonable in the circumstances. However, we do not undertake to update any such forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws in Canada . There can be no assurance that such estimates and assumptions will prove to be correct.  Many factors could cause our actual results, level of activity, performance or achievements or future events or developments to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the factors discussed in the “Risks and Uncertainties” section of the Company’s Annual Information Form dated January 22, 2018 (“AIF”). A copy of the AIF and the Company’s other publicly filed documents can be accessed under the Company’s profile on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at The Company cautions that the list of risk factors and uncertainties described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking information and are cautioned not to place undue reliance on such information.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE The Supreme Cannabis Company, Inc.

For further information: Contact Information: Investor Relations, Jenni Byrne, Bayfield Strategy, Inc., Phone: 416-466-6265, Email:, Website: